Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and Lupus Erythematosus, Cutaneous, Subacute

pyrazines has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baltaci, M; Böckle, BC; Sepp, NT; Weyrer, W1
Aguayo-Leiva, I; Carrillo-Gijon, R; Jaén-Olasolo, P; Vano-Galvan, S1
Heelan, K; McKenna, DB1

Other Studies

3 other study(ies) available for pyrazines and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Bortezomib-induced lupus erythematosus tumidus.
    The oncologist, 2009, Volume: 14, Issue:6

    Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Exanthema; Female; Humans; Lupus Erythematosus, Cutaneous; Pyrazines

2009
Lupus tumidus induced by bortezomib not requiring discontinuation of the drug.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:11

    Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Lupus Erythematosus, Cutaneous; Male; Multiple Myeloma; Pyrazines

2010
Bortezomib-induced cutaneous lupus in a patient with myeloma.
    The Journal of dermatology, 2013, Volume: 40, Issue:2

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence

2013